The Chadian capital, N’Djamena, has become the focal point for the 25th International Pharmaceutical Forum, drawing together a diverse assembly of experts, healthcare professionals, and delegates from numerous African nations. This significant gathering is dedicated to the crucial theme of enhancing healthcare access, with a strong emphasis on boosting local pharmaceutical manufacturing and tackling the persistent challenges within the continent’s health sector.
Representing the President of the Republic, Prime Minister Allah Maye Halina extended a warm welcome to all delegations from sister and friendly countries converging in N’Djamena. He highlighted that their presence not only honored Chad but also underscored a shared commitment to strengthening cooperation in the vital domain of health.
It is with immense pleasure that the Republic of Chad hosts this 25th International Pharmaceutical Forum, having previously been the venue for its 13th edition. This assembly serves as an invaluable platform for constructive dialogue, sharing of experiences, and collaboratively seeking resolutions to contemporary health challenges. More than just a forum for scientific discourse, this event is designed to guide public policy, ensuring that its deliberations and recommendations translate into concrete actions benefiting the population.
The Prime Minister underscored the imperative for Africa to cultivate the capacity to produce a greater volume of essential medicines, vaccines, medical devices, and other critical health products, thereby meeting the needs of its people. He further affirmed the Chadian government’s ongoing commitment to fortifying its healthcare system, broadening access to medical services, and reinforcing national pharmaceutical capabilities.
Dr. Abdelmadjid Abderahim Mahamat, the Minister of Public Health and Prevention, articulated that this forum presents an unparalleled opportunity for participants to engage in meaningful exchanges, share insights, and forge enduring partnerships. He stressed the collective responsibility to pinpoint concrete solutions addressing challenges such as ensuring access to quality medications, refining pharmaceutical regulations, enhancing training initiatives, and fostering innovation.
Speaking on behalf of InterOrdre, Mr. Laroussi Mustapha noted the particular significance of opening this 25th International Pharmaceutical Forum, which is themed: “Renforcer l’accès aux soins de santé : opportunités et défis de la fabrication locale et de la pharmacie hospitalière” (Strengthening Healthcare Access: Opportunities and Challenges of Local Manufacturing and Hospital Pharmacy).
He emphasized that this theme resonates deeply with their core mission, recognizing that every medication impacts a patient, every pharmacy serves a family, and every decision holds a human life in balance. Mr. Mustapha also highlighted the indispensable role of hospital pharmacy as a cornerstone for the safety and quality of care, serving as a genuine beacon of hope for communities.
This high-level gathering thus provides a crucial opportunity for stakeholders across the pharmaceutical sector to collectively strategize on methods for sustainably improving healthcare access and bolstering the health sovereignty of African nations.
